Hser Y I, Anglin M D, Fletcher B
UCLA Drug Abuse Research Center, Neuropsychiatric Institute 90024-3511, USA.
J Subst Abuse Treat. 1998 Nov-Dec;15(6):513-23. doi: 10.1016/s0740-5472(97)00308-5.
This study examined treatment outcome as a function of program modality, clients' lifetime patterns of drug dependence, and their interaction, controlling for current level of drug use at treatment intake. Data were based on 2,966 clients who were interviewed at intake and at 1-year follow-up as part of the Drug Abuse Treatment Outcome Study (DATOS), which included programs of four major modalities. Subjects' lifetime patterns of drug dependence were classified into nine groups according to Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R; American Psychiatric Association; 1987) diagnostic criteria and time of onset of drug use career. Outcome measure was the reduction of heroin use or cocaine use at follow-up from levels at intake. The results showed that rates of lifetime drug dependence and current drug use at DATOS admission were highest among methadone maintenance clients and lowest among outpatient drug-free clients. Drug use reduction was observed for all modalities. The presence of dependence diagnosis was associated with less improvement when current use level at intake was controlled. Clients dependent on heroin but not currently daily users benefited most from inpatient and residential programs. Methadone programs were also relatively ineffective in reducing cocaine use. Characteristics of the client's drug dependence history, in addition to the current or presenting drug problem, should be assessed to guide treatment planning. The high rate of cocaine dependence among methadone clients, most of whom were dependent on heroin, poses considerable challenge to contemporary opiate substitution treatments.
本研究考察了治疗结果作为治疗方式、客户药物依赖的终生模式及其相互作用的函数,同时控制治疗开始时的当前药物使用水平。数据基于2966名客户,他们在治疗开始时和1年随访时接受了访谈,这是药物滥用治疗结果研究(DATOS)的一部分,该研究包括四种主要治疗方式的项目。根据《精神疾病诊断与统计手册》(DSM-III-R;美国精神病学协会;1987年)的诊断标准和药物使用生涯的开始时间,将受试者的药物依赖终生模式分为九组。结果指标是随访时海洛因使用量或可卡因使用量相对于治疗开始时水平的减少情况。结果显示,在美沙酮维持治疗客户中,终生药物依赖率和DATOS入院时的当前药物使用率最高,而在门诊无药物治疗客户中最低。所有治疗方式都观察到了药物使用量的减少。在控制了治疗开始时的当前使用水平后,存在依赖诊断与改善较少相关。依赖海洛因但目前不是每日使用者的客户从住院和寄宿项目中受益最大。美沙酮项目在减少可卡因使用方面也相对无效。除了当前或呈现的药物问题外,还应评估客户药物依赖史的特征,以指导治疗计划。美沙酮客户中可卡因依赖率很高,其中大多数人还依赖海洛因,这给当代阿片类药物替代治疗带来了相当大的挑战。